We are thrilled to share that HEMEX is part of the investment consortium financing the series B1 of hemotune AG. Furthermore, we look forward to supporting them on their journey to making the HemoSystem available to patients globally!
hemotune_Press Release B Funding Round
HEMEX is committed to changing the future of healthcare by guiding the most promising European startups through each and every step to bring innovative pharmaceuticals, medical devices, and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure startups have access to a wide range of tailored products, practical solutions, and fundraising support. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare. For more information, visit https://hemex.ch/